Successful Treatment of Myocardial Infarction in an Infant with Kawasaki Disease

Pei Ni Jone*, Daniel Tapia, Jesse Davidson, Thomas E. Fagan, Lorna Browne, Richard John Ing, Joseph Kay

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Although early treatment with intravenous immunoglobulin reduces the risk of coronary artery aneurysms, in refractory cases of Kawasaki disease, myocardial infarction can result from thrombosis of coronary artery aneurysms. Early recognition of myocardial infarction from Kawasaki disease myocarditis can reduce morbidity and mortality. This report describes successful treatment of myocardial infarction from coronary thrombosis in an infant with Kawasaki disease using intravenous tissue plasminogen activator and abciximab.

Original languageEnglish (US)
Pages (from-to)255-259
Number of pages5
JournalSeminars in Cardiothoracic and Vascular Anesthesia
Issue number3
StatePublished - Sep 21 2015


  • abciximab
  • coronary artery aneurysms
  • coronary artery thrombosis
  • Kawasaki disease
  • myocardial infarction
  • thrombolytics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Successful Treatment of Myocardial Infarction in an Infant with Kawasaki Disease'. Together they form a unique fingerprint.

Cite this